Oxford Endovascular is a spin out  from Oxford University developing technology to prevent brain haemorrhage.

OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️  is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan.

Created by world experts in the field, OxiFlow™ has gone through proof of concept pre-clinical studies that will be followed by a 1st in human study en-route to gaining FDA & CE mark.

Oxford Endovascular Ltd.

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Apple Mobile Web Clips Icon

Google Font API

WordPress

Font Awesome

DoubleClick.Net

Apache

Chief Executive Officer

Mike Karim

Vice President Regulatory Affairs and Quality Assurance

Rebecca Sheridan

Director of Development

Andrew Moor

Research and Development Engineer

Jodi Collins

Ian Broadhurst

James Byrne

Clinical Director

CEO and Co-founder

Zhong You

Technology Director

Brian Howlett

Chairman

Health Care Early Stage Companies With Fewer Than 100 Employees

Europe Companies With Less Than $500M in Revenue (Top 10K)

Europe, Middle East, and Africa (EMEA) Early Stage Companies With More Than $1M in Revenue

Medical Early Stage Companies With Fewer Than 10 Employees

Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.  This diverts the blood away from the aneurysm, allowing it to heal.

Parkwalk Advisors

Series A - Oxford Endovascular

MedTech Innovator

Non Equity Assistance - Oxford Endovascular

Vulpes Investment Management Pte Ltd

Innovate UK

Grant - Oxford Endovascular

EIT Health

Venture Round - Oxford Endovascular

Seed Round - Oxford Endovascular

Oxford

Oxfordshire

United Kingdom

Europe

Oxford Endovascular

Oxford Endovascular secures £8 million to take novel brain aneurysm tech to human trials

Oxford Endovascular, an origami-inspired startup raises £8M to fight brain aneurysms — TFN

Oxford Endovascular Closes GBP8M Series A+ Funding

Oxford Endovascular, an origami-inspired startup raises £8M to fight brain aneurysms

A flow-diverter stent designed to treat intracranial aneurysms by diverting blood flow away from aneurysms at risk of rupture. It is laser-cut from Nitinol and aims to reduce complications by conforming better to blood vessels.

Penumbra is a company that develops and manufactures medical devices for neurovascular and peripheral vascular applications.

Penumbra

Rapid Medical is a medical device company focused on the development of neurovascular devices for the treatment of stroke and aneurysms.

Rapid Medical

Stryker is a leading global medical technology company that offers a wide range of products and services in the neurovascular field.

Stryker

Johnson & Johnson is a multinational corporation with a significant presence in the healthcare industry, including neurovascular devices.

Johnson & Johnson

Medtronic plc is a global leader in medical technology, services, and solutions, including neurovascular interventions.

Medtronic plc

Terumo Corporation is a Japanese multinational medical devices and pharmaceutical company with a focus on neurovascular interventions.

Terumo Corporation

Oxford Endovascular Ltd is a medical device company that specializes in the development of innovative solutions to treat brain hemorrhages. The company's flagship product, the Origami device, is designed to prevent brain hemorrhage and is based on technology developed at the University of Oxford's Department of Physics.

Oxford Endovascular Ltd

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 21, 2024 10:05 PM	5121a4c0
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 12:44 AM	91dc2019
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	a4738241
crunchbase profile	general	Nov 25, 2024 11:08 AM	5913801a
li profile	general	Jun 21, 2024 10:05 PM	82d74866
translate crunchbase fundingrounds	general	Nov 25, 2024 2:12 PM	fa6ee759
peers	general
news basic	general	Jun 21, 2024 10:05 PM	68703ec5
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:OXFORDENDOVASCULAR

Oxford Endovascular Ltd